On Friday, Mersana Therapeutics Inc (NASDAQ: MRSN) opened lower -0.71% from the last session, before settling in for the closing price of $1.40. Price fluctuations for MRSN have ranged from $1.22 to $6.28 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 15390.52% annually for the last half of the decade. Company’s average yearly earnings per share was noted 60.21% at the time writing. With a float of $86.56 million, this company’s outstanding shares have now reached $122.87 million.
In an organization with 123 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 48.0%, operating margin of -228.07%, and the pretax margin is -212.99%.
Mersana Therapeutics Inc (MRSN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mersana Therapeutics Inc is 29.93%, while institutional ownership is 59.60%. The most recent insider transaction that took place on Oct 28 ’24, was worth 3,580. In this transaction SVP, Chief Development Officer of this company sold 1,884 shares at a rate of $1.90, taking the stock ownership to the 54,731 shares. Before that another transaction happened on Oct 28 ’24, when Company’s Officer proposed sale 1,884 for $2.04, making the entire transaction worth $3,843.
Mersana Therapeutics Inc (MRSN) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 60.21% per share during the next fiscal year.
Mersana Therapeutics Inc (NASDAQ: MRSN) Trading Performance Indicators
Check out the current performance indicators for Mersana Therapeutics Inc (MRSN). In the past quarter, the stock posted a quick ratio of 2.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Mersana Therapeutics Inc (MRSN)
Let’s dig in a bit further. During the last 5-days, its volume was 1.91 million. That was inferior than the volume of 2.11 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 11.31%. Additionally, its Average True Range was 0.21.
During the past 100 days, Mersana Therapeutics Inc’s (MRSN) raw stochastic average was set at 10.56%, which indicates a significant increase from 4.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 100.43% in the past 14 days, which was lower than the 109.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.0570, while its 200-day Moving Average is $2.3110. However, in the short run, Mersana Therapeutics Inc’s stock first resistance to watch stands at $1.4400. Second resistance stands at $1.4900. The third major resistance level sits at $1.5250. If the price goes on to break the first support level at $1.3550, it is likely to go to the next support level at $1.3200. Assuming the price breaks the second support level, the third support level stands at $1.2700.
Mersana Therapeutics Inc (NASDAQ: MRSN) Key Stats
There are currently 123,533K shares outstanding in the company with a market cap of 170.48 million. Presently, the company’s annual sales total 36,860 K according to its annual income of -171,670 K. Last quarter, the company’s sales amounted to 12,600 K and its income totaled -11,500 K.
